The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase II study of fosaprepitant +5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: A Hoosier Cancer Research Network Study.

Mary J.  Brames

No Relationships to Disclose

Somer  Case-Eads

No Relationships to Disclose

Nasser H.  Hanna

Research Funding - Merck KGaA (Inst)

Christopher A.  Fausel

No Relationships to Disclose

Timothy  Breen

No Relationships to Disclose

Lawrence H.  Einhorn

Stock and Other Ownership Interests  - Amgen; Biogen

Speakers' Bureau - Celgene; ZIOPHARM Oncology